Read + Share
Alayoubi AM, Khawaji ZY, Mohammed MA, Mercier FE, et al. CRISPR-Cas9 system: a novel and promising era of genotherapy for
beta-hemoglobinopathies, hematological malignancy, and hemophilia. Ann Hematol 2024;103:1805-1817.
PMID: 37736806
|
 |
|
Alayoubi AM, Khawaji ZY, Mohammed MA, Mercier FE, et al. CRISPR-Cas9 system: a novel and promising era of genotherapy for
beta-hemoglobinopathies, hematological malignancy, and hemophilia. Ann Hematol 2024;103:1805-1817.
PMID: 37736806
|
|
|
|